Compare HCSG & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCSG | CDNA |
|---|---|---|
| Founded | 1976 | 1998 |
| Country | United States | United States |
| Employees | N/A | 765 |
| Industry | Assisted Living Services | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 1994 | 2007 |
| Metric | HCSG | CDNA |
|---|---|---|
| Price | $24.87 | $28.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $22.67 | ★ $28.00 |
| AVG Volume (30 Days) | 729.3K | ★ 917.0K |
| Earning Date | 04-22-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.83 | N/A |
| EPS | ★ 0.37 | 0.05 |
| Revenue | ★ $1,837,173,000.00 | $48,324,000.00 |
| Revenue This Year | $7.39 | $16.01 |
| Revenue Next Year | $5.22 | $11.31 |
| P/E Ratio | ★ $67.97 | $583.80 |
| Revenue Growth | 7.08 | ★ 18.93 |
| 52 Week Low | $12.66 | $10.96 |
| 52 Week High | $25.55 | $30.00 |
| Indicator | HCSG | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 78.53 | 70.95 |
| Support Level | $18.36 | $14.59 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.71 | 1.43 |
| MACD | 0.27 | 0.39 |
| Stochastic Oscillator | 89.87 | 88.86 |
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company manages and evaluates its operations in two reportable segments: Environmental Services segment includes housekeeping, management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services, linen and other services; and Dietary Segment includes dietary department services, food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America. The Environmental Services segment derives maximum revenue.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.